Analyst Price Targets — SRRK
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 8, 2026 10:35 am | — | Barclays | $55.00 | $46.45 | TheFly | Scholar Rock price target raised to $55 from $53 at Barclays |
| May 8, 2026 10:22 am | — | H.C. Wainwright | $65.00 | $46.45 | TheFly | Scholar Rock price target raised to $65 from $58 at H.C. Wainwright |
| April 20, 2026 8:21 pm | — | Canaccord Genuity | $62.00 | $47.80 | TheFly | Scholar Rock initiated with a Buy at Canaccord |
| March 4, 2026 12:55 pm | Allison Bratzel | Piper Sandler | $58.00 | $44.85 | StreetInsider | 'We are incrementally positive on Scholar Rock (SRRK) Shares'; PT Raised at Piper Sandler |
| March 3, 2026 9:01 pm | Etzer Darout | Barclays | $53.00 | $44.31 | StreetInsider | Scholar Rock (SRRK) PT Raised to $53 at Barclays |
| March 3, 2026 6:54 pm | Srikripa Devarakonda | Truist Financial | $55.00 | $44.31 | StreetInsider | Scholar Rock (SRRK) PT Raised to $55 at Truist Securities |
| January 26, 2026 11:16 am | Andres Maldonado | H.C. Wainwright | $58.00 | $44.29 | TheFly | Scholar Rock price target raised to $58 from $44 at H.C. Wainwright |
| January 7, 2026 6:02 am | Michael Yee | UBS | $60.00 | $41.31 | StreetInsider | UBS Starts Scholar Rock (SRRK) at Buy |
| December 17, 2025 10:58 am | Etzer Darout | Barclays | $52.00 | $44.32 | TheFly | Scholar Rock price target raised to $52 from $45 at Barclays |
| November 14, 2025 5:48 pm | — | BMO Capital | $50.00 | $37.41 | TheFly | Scholar Rock price target raised to $50 from $45 at BMO Capital |
Latest News for SRRK
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 118,586 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to purchase an aggregate of 33,987 shares of common stock and inducement restricted stock units, covering an aggregate of 84,599 shares of its…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management at 8:00 a.m. ET. To access the live audio webcast, please go to “Events and Presentations” in the Investors section of the Scholar Rock…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, announced today that it will present new clinical data and research updates at Cure SMA's Annual…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 134,345 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to purchase an aggregate of 50,936 shares of common stock and inducement restricted stock units, covering an aggregate of 83,409 shares of its…
Scholar Rock Holding Corporation (SRRK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SRRK.
U.S. House Trading
No House trades found for SRRK.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.